Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-10

Clinical Trial Update: Buprenorphine for Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating buprenorphine for cancer-related pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Cancer-Related Pain | Phase 4 | Status: UNKNOWN